A novel framework for nanomedicine development
- Institution
- University of Oklahoma Norman Campus, OK
- Principal investigator
- Stefan Wilhelm
- Funding
- $373K
- Duration
- 2023–2028
Moonbase score
Still being scored
Abstract
Project Summary Nanomedicine is a research field centered around applying materials in the nanoscale size range (i.e. nanoparticles) as therapeutics and diagnostics. However, a major challenge is the safe, efficient, and effective delivery of nanoparticles to biological systems, such as cells, tissues, and organs. In this project, we will introduce and explore a novel framework for nanomedicine development with the ultimate goal of efficiently delivering non- viral nanoparticles to cells and tissues for safe and effective applications. Our proposed research program has three main strands: (i) we will develop novel nanoparticles for the safe, efficient, and effective delivery of small molecules and nucleic acid payloads to skeletal muscle cells; (ii) we will develop novel methods for super- resolution bioimaging to study the mechanisms and kinetics of nanoparticle spatiotemporal transport in biological systems; (iii) we will quantify safety, efficiency, and effectiveness of nanoparticle in vivo delivery. Using this novel framework, our long-term scientific goal is to create a major breakthrough in nanomedicine by developing safer, more efficient, and more effective nanoparticles for the non-viral delivery of small molecule-based drugs and nucleic acid payloads to enable therapeutic applications in skeletal muscle disorders.
LOADING MOONBASE SCORE
Questions for University of Oklahoma Norman Campus
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · University of Oklahoma Norman Campus66
Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system
Resham Bhattacharya · $367K · 2021–2026
- NIH · University of Oklahoma Norman Campus60
Exploiting gold nanoparticle as a probe to identify therapeutic targets
Resham Bhattacharya · $355K · 2021–2027
- NIH · University of Oklahoma Norman Campus58
Proteomics Core
Michael T Kinter · $250K · 2001–2030